Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 K-ras mutations in pancreatic ductal proliferative lesions.

Literature DB >> 7992857

K-ras mutations in pancreatic ductal proliferative lesions.

D S Klimstra, D S Longnecker.

Abstract

Entities: Disease Gene

Mesh：

Year: 1994 PMID： 7992857 PMCID： PMC1887480

Source DB: PubMed Journal: Am J Pathol ISSN： 0002-9440 Impact factor: 4.307

× No keyword cloud information.

11 in total

1. Borderline epithelial lesions of the breast.

Authors: J Rosai
Journal: Am J Surg Pathol Date: 1991-03 Impact factor: 6.394

2. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

Authors: M Tada; M Omata; S Kawai; H Saisho; M Ohto; R K Saiki; J J Sninsky
Journal: Cancer Res Date: 1993-06-01 Impact factor: 12.701

3. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases.

Authors: M Tada; M Omata; M Ohto
Journal: Cancer Date: 1991-02-01 Impact factor: 6.860

4. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis.

Authors: G Klöppel; G Bommer; K Rückert; G Seifert
Journal: Virchows Arch A Pathol Anat Histol Date: 1980

5. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

Authors: J A DiGiuseppe; R H Hruban; G J Offerhaus; M J Clement; F M van den Berg; J L Cameron; A D van Mansfeld
Journal: Am J Pathol Date: 1994-05 Impact factor: 4.307

6. Dysplasia and carcinoma in situ of the exocrine pancreas.

Authors: T Mukada; S Yamada
Journal: Tohoku J Exp Med Date: 1982-06 Impact factor: 1.848

7. Relation of pancreatic duct hyperplasia to carcinoma.

Authors: S Kozuka; R Sassa; T Taki; K Masamoto; S Nagasawa; S Saga; K Hasegawa; M Takeuchi
Journal: Cancer Date: 1979-04 Impact factor: 6.860

8. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

Authors: A Yanagisawa; K Ohtake; K Ohashi; M Hori; T Kitagawa; H Sugano; Y Kato
Journal: Cancer Res Date: 1993-03-01 Impact factor: 12.701

9. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.

Authors: A L Cubilla; P J Fitzgerald
Journal: Cancer Res Date: 1976-07 Impact factor: 12.701

Review 10. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases.

Authors: P M Pour; S Sayed; G Sayed
Journal: Am J Clin Pathol Date: 1982-02 Impact factor: 2.493

58 in total

1. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.

Authors: David Z Chang; Ying Ma; Baoan Ji; Huamin Wang; Defeng Deng; Yan Liu; James L Abbruzzese; Yong-jun Liu; Craig D Logsdon; Patrick Hwu
Journal: Clin Cancer Res Date: 2011-10-05 Impact factor: 12.531

Review 2. Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors: André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal: Langenbecks Arch Surg Date: 2010-03-18 Impact factor: 3.445

Review 3. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors: Andrew D Rhim; Ben Z Stanger
Journal: Prog Mol Biol Transl Sci Date: 2010 Impact factor: 3.622

K-ras mutations in pancreatic ductal proliferative lesions.

1. Borderline epithelial lesions of the breast.

2. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

3. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases.

4. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis.

5. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

6. Dysplasia and carcinoma in situ of the exocrine pancreas.

7. Relation of pancreatic duct hyperplasia to carcinoma.

8. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

9. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.

Review 10. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases.

1. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.

Review 2. Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Review 3. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

4. Changes in connexin43 expression and localization during pancreatic cancer progression.

Review 5. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

6. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.

Review 7. Pancreatic cancer - a continuing challenge in oncology.

8. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Review 9. Pancreatic cancer and the FAMMM syndrome.

10. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.